The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.
"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."
As part of our on-going member support, we are introducing a new website feature to help with common practice management challenges. We welcome your input with questions or challenges you would like to address. Read More
In early March, Congress adopted legislation that updated the Medicare Physician Fee Schedule (MPFS) conversion factor for…
On Saturday, March 9, the Centers for Medicare & Medicaid Services (CMS) released a statement…
President Biden’s State of the Union Address State of the Union Transcript State of the Union Video…
08/08/25: Scientific Abstract Submission Deadline
Learn more
12/01/25: Research Grant Cycle
Learn more
06/01/26: Fellow Exam Application Deadline
Learn more
06/01/26: Research Grant Cycle
Learn more
This fall, November 14-16, take your learning to the next level—while soaking up the coastal beauty of Oceanside, CA, by attending the 2025 AAOA Annual Meeting. Whether you’re a seasoned ENT allergy provider or building a new service line, the 2025 AAOA Annual Meeting brings you cutting-edge education, actionable practice tips, and networking opportunities. Register Today
Focusing on surgical and medical management of airway disease in ENT, the Explorers Course 2026 will focus on the "sinus” headache, ocular manifestations of allergies and treatments beyond antihistamine eye drops, food allergy, microbiome and allergies/sinusitis, changing environment, and more. Learn about the Explorers Course 2026 here.
We are pleased to invite you to participate in the 2025 AAOA Annual Meeting Call for Proposals. Do you have burning content ideas to be presented at the Annual Meeting? The AAOA is seeking proposals to incorporate in the educational sessions for the 2025 Annual Meeting. Learn More
For information about Resident membership, opportunities, DosedDaily, research grants, and other resources. Learn More
IFAR Impact Factor: 2.454
IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More
Explorers Course 2026:
Surgical & Medical Management of Airway Disease in Otolaryngology — Hybrid
90-days Access December 22-March 23, 2026
January 22-24, 2026 - Live
Fairmont Sonoma Mission Inn & Spa,
Sonoma, CA
Learn More and Register
2026 AAOA Basic Course in Allergy & Immunology – Hybrid
90-days Access June 9– Sep 14, 2026
July 9-11, 2026 – Live
The Diplomat, Hollywood, Florida
Book Your Room
USP 797 Online Module
Learn More and Register
AAOA Educational Stacks
Available October 1 - December 31, 2025
Practice Corner FAQ’s https://youtu.be/F7rlAIK27bc We receive regular questions about when to use modifiers. The video…
“Don’t follow the crowd, let the crowd follow you” — Margret Thatcher This morning I…
Join Haidy Marzouk, MD, FAAOA, and Nalin Patel, MD, FAAOA as they delve into the…
The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.
AAOA has launched a Partner Resource Center to bring you partner resources that can assist your practice and patient care.
FDA has a drug shortage database which includes reasons for and updates on drug shortages. Today the database read, “Meridian Medical Technologies, a subsidiary of Pfizer that manufactures EpiPen® and the authorized generic version,…
by Kristin Seiberling, MD, AAOA Board of Directors Electronic health record (EHR) has become an integral component of health care and is the crusade of the future. It has many positive attributes…
Many otolaryngologists and their practice administrators confuse marketing and advertising, thinking marketing is limited to advertising to attract new patients. Learn More
By AAOA Leadership Change is the only constant in life and medicine to borrow from the Greek philosopher. The significant changes afoot in the realm of allergy socioeconomic issues prove…
As we continue to monitor activity both at the FDA and USP in relation to physician compounding, we wanted to offer the latest update. USP: To provide a unified approach…
Several Medicare contractors have initiated prepayment audits of billings for immunotherapy billings and documentation has been requested to support the medial necessity of the claims. Under Medicare law, only items…
In late November 2013, Congress passed the Compounding Bill. This legislation enforces regulation of compounding pharmacies, as a result of injections of contaminated compounded drugs - which caused 64 deaths…
Please refer to the updated version of the Clinical Care Statements that can be found here. In response to member requests, the AAOA Board of Directors recently adopted the following…
For members with questions about coding, regulations, or other practice resources, contact our Advocacy Team at advocacy@aaoallergy.org.
The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and…